MCM
VNDA icon

Matarin Capital Management’s Vanda Pharmaceuticals VNDA Stock Holding History

Matarin Capital Management’s Portfolio VNDA Stock Details VNDA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		$423K Sell
32,202
-27,932
-46% -$336K 0.1% 168
2020
Q3 		$581K Buy
60,134
+28,386
+89% +$303K 0.12% 171
2020
Q2 		$363K Buy
+31,748
New +$359K 0.07% 180
2017
Q4 		– Sell
-38,075
Closed -$682K – 319
2017
Q3 		$682K Hold
38,075
– – 0.06% 221
2017
Q2 		$621K Sell
38,075
-25,002
-40% -$360K 0.06% 207
2017
Q1 		$883K Buy
+63,077
New +$899K 0.09% 197

Other funds holding VNDA

BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
AC
Armistice Capital New York $3.03B AUM 36.06% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Prudential Financial
Prudential Financial Newark, New Jersey $81.2B AUM 27.81% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return